Save Up To 70% with generic medications and up to 40% with brand name drugs. Get FREE WorldWide shipping on $149 or more...
Diabetes » Insulin Glargine - European Medicines...
Home » News » Insulin Glargine - European Medicines...
Insulin Glargine - European Medicines Agency Update On Safety
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that there is no cause for concern of the risk of cancer for people with diabetes on insulin glargine (Lantus).
Read full article @ MedicalNewsToday
Read Also Other "Diabetes" News
-
CHMP Recommends 'Januvia(R)'(sitagliptin), From MSD, For Restricted First Line Use In European Union
Merck & Co., Inc. (Whitehouse Station, N.J., U.S.A.), which operates in many...
-
DRSI Launches The First And Only Diabetes Energy Formula Specifically Created For Diabetics To Counter Their No. 1 Complaint: Fatigue
Diabetica Research Solutions, Inc. (DRSI) http://www.drsirestoreenergy.com:...
-
Efforts To Create Treatment Guidelines Are Often Complicated
The development of treatment guidelines for illnesses such as diabetes is a...
